Currently, Dr. Lavan is an Associate Professor at the Faculty of Natural Sciences and Mathematics and a postgraduate instructor at the National University Federico Villarreal. He is also a researcher at CONCYTEC. The technological developments he has created have led him to become the CEO of INTIBIOTECH2 in Toronto, Canada, and the founder of BIOTECHCELL SAC in Peru, both companies focused on technological innovation in biotechnology and space exploration. He has implemented two technological developments: the first in microgravity, creating a microgravity machine for biological and pharmaceutical experiments, which has been granted a patent in collaboration with INGESEA AUTOMATION SL (https://ingesea.com/es/) and GAIA (https://gaia.es/) from the Basque Country, Spain. The second is a new method for disease diagnosis using Biochip technology.
Among his research and innovation work, the detection of SARS-CoV-2 through the immobilization of a Chimera I called FT4_Angiotensin II_C on a gold screen-printed electrode adapted to an electronic circuit stands out. He is also in the process of validating an antiviral for COVID-19 using Chimera II, FT4_Angiotensin II, both designed by Dr. Laván’s team and synthesized in the GENSCRIPT laboratories in the USA. Additionally, he is the principal investigator of the neutralizing antibodies project for SARS-CoV-2, which has been approved by the ethics committee of the Regional Hospital of Lambayeque. The development of his research on the COVID-19 pandemic is supported by the private company GERESA from Lambayeque, ESSALUD, and national companies that have collaborated with Dr. Laván.
He has generated over 1.3 million soles in public project funding through the InnovatePeru calls and 0.75 million soles in private funding for the development and implementation of applied research projects. Thanks to these competitive funds, in 2013 and 2014, he established the first microgravity laboratory in Peru and built the microgravity machine, which is the third in the world and the first in Peru. Between 2014 and 2015, he implemented the first fluorescence microscope integrated into the microgravity machine. In 2015, he presented the first project for the construction of a genosensor.
Dr. Laván holds an international patent PCT/ES2018/070311 (microgravity machine for biological experiments), a patent application submitted to INDECOPI in December 2021, which reflects the results of Agreement No. 27 FIDECOM-INNOVATEPERU-PIPEI-2018 (microlayer detection system using lasers). He also holds a patent feasibility report for a Biochip and is in the process of obtaining a patent for two CHIMERAS and a kit for diagnosing neutralizing antibodies for SARS-CoV-2.
Dr. Laván has worked as a faculty member at the Faculty of Natural Sciences and Mathematics at the National University Federico Villarreal. He has also taught at the Universidad Peruana Cayetano Heredia in the Biomedical Engineering program and is a research professor at the Faculty of Medicine at the Universidad Ricardo Palma. He worked as a faculty member at the National University of San Marcos, the National University of Engineering, the National University of Callao, and as a specialized researcher in the Research and Technological Development Department at INICTEL-UNI from September 2012 to June 2020.
Internationally, he has worked as a researcher at the Microgravity Laboratory of the European Space Agency in the Netherlands and has participated in collaborative projects with the University of Castilla La Mancha, the Teófilo Hernando Foundation Institute at the Autonomous University of Madrid, the company GAIA, and the Research and Technological Development Center for Electrochemistry in Querétaro, Mexico.
In March 2012, he graduated as a Doctor in Biochemistry, Molecular Biology, and Biomedicine, defending his thesis titled «Gene Expression Analysis in Drosophila melanogaster Pupae Exposed to Microgravity.» In February 2009, the Autonomous University of Madrid awarded him a Master’s degree in Biophysics. From 1997 to 1999, he pursued a Master’s in Theoretical Physics at the Pontifical Catholic University of Peru. In early 2001, the National University of Trujillo granted him a Bachelor’s degree in Physics with honors. He was employed by the Autonomous University of Madrid as a researcher in training from 2009 to 2011.
In February 2007, he entered the field of biochemistry as a data analyst for mRNA expression chips of microarrays, from Drosophila melanogaster pupae sent to the International Space Station. From February 2006 to February 2007, he was part of the patent categorization team at the Spanish Patent and Trademark Office in Madrid.
Additionally, Dr. Laván has published in various scientific journals both nationally and internationally and maintains a dynamic and ongoing scientific and technological production..
Spanish 
English